Big shifts GLP-1 market include FDA approval of oral weight loss drugs and expanded Medicare coverage starting July 2024 for key GLP-1 therapies.

GLP-1 users reported benefits that reached beyond weight loss—along with real challenges around stigma, uncertainty, and ...

A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to ...

Insurance coverage for GLP-1 medications is more likely for type 2 diabetes than for weight loss. Coverage for weight loss depends on your specific insurance plan, as some employers exclude it.

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...